Journal of The Korean Society of Inherited Metabolic disease (대한유전성대사질환학회지)

The Korea Society of Inherited Metabolic Disease (대한유전성대사질환학회)
권호 표지

Clinical and Molecular Characterization of Korean Patients with Glycogen Storage Type 1b

당원병1b형의 임상양상 및 분자유전학적 특징

  • Cho, Ja Hyang (Department of Pediatrics, Asan Medical Center Children's Hospital, University of Ulsan College of Medicine) ;
  • Kim, Yoo-Mi (Department of Pediatrics, College of Medicine, Busan National University) ;
  • Choi, Jin-Ho (Department of Pediatrics, Asan Medical Center Children's Hospital, University of Ulsan College of Medicine) ;
  • Lee, Beom Hee (Department of Pediatrics, Asan Medical Center Children's Hospital, University of Ulsan College of Medicine) ;
  • Kim, Gu-Hwan (Yangsan Medical Genetics Center, Asan Medical Center) ;
  • Yoo, Han-Wook (Department of Pediatrics, Asan Medical Center Children's Hospital, University of Ulsan College of Medicine)
  • 조자향 (울산대학교 의과대학 소아청소년과) ;
  • 김유미 (부산대학교 의과대학 소아청소년과) ;
  • 최진호 (울산대학교 의과대학 소아청소년과) ;
  • 이범희 (울산대학교 의과대학 소아청소년과) ;
  • 김구환 (서울아산병원 의학유전학센터) ;
  • 유한욱 (울산대학교 의과대학 소아청소년과)
  • Published : 2015.04.25
Download PDF
⟨ Previous Next ⟩

Abstract

Glycogen storage disease type Ib (GSD Ib) is one of the rare inherited metabolic disease caused by mutation of SLC37A4 gene. Clinical characteristics include hepatomegaly, hypoglycemia, lactic acidosis, hyperlipidemia and high serum uric acid concentration. The authors analyzed clinical and molecular characteristics of three Korean patients (one male and two females) with GSD Ib by retrospective review of medical records. Two patients were diagnosed in toddler period by hypoglycemia and hepatomegaly. One patient was diagnosed by growth retardation and short stature in puberty. c.412T>C (p.Trp138Arg) (3/6 alleles, 50.0%) was most frequently observed, following by p.Leu348Valfs*53 (1 allele), p.Pro191Leu (1 allele), p.Ala148Val (1 allele) in molecular analysis. Uncooked corn starch and allopurinol was administered. Because all three patients had neutropenia and recurrent infections, G-CSF was administered. Two patients had severe osteoporosis needing calcium supplement. The patient who diagnosed at puberty had relatively poor prognosis demonstrated by having severe infection and complications in liver and kidney.

당원병 Ib형은 드문 유전 대사 질환 중 하나로 SLC37A4 유전자의 장애로 인해 발생한다. 특징적으로 간비대, 저혈당, 고젖산혈증, 고지혈증, 고뇨산증의 임상양상을 보인다. 총 3명(남자 1명, 여자 2명)이 포함되었고 의무기록을 후향적으로 분석하였다. 평균 진단시 나이는 각각 8개월, 26개월, 10세이다. 2명의 환자가 영유아기에 간비대, 저혈당 등으로 발견되었고, 다른 환자는 사춘기에 성장 발육 부전으로 인한 저신장으로 진단되었다. 유전학적 검사에서 c.412T>C (p.Trp 138Arg) (3/6 alleles, 50.0%)가 가장 흔했고 다음으로 p.Leu348Valfs*53 (1 allele), p.Pro191Leu (1 allele), p.Ala148Val (1 allele)가 확인되었다. 요산 강하제, 생 옥수수 전분 복용을 시작하였으며, 모든 환자가 중성구 감소 소견이 관찰되어 G-CSF 투여하였다. 이들 모두 구내염, 장염, 뇌농양과 같은 반복적인 감염이 관찰되었다. 또한 2명은 심한 골다공증으로 칼슘 보충제가 필요하였다. 비교적 일찍 진단된 2명에 비해 10세에 진단된 경우 중증 감염 및 간과 신장의 합병증을 보이고 있었다. 통계학적으로 유의하지 않지만, 비교적 전자의 환자들이 비교적 예후가 좋았다. 본 연구를 통해 동시에 한국의 GSD Ib형 환자의 임상적, 생화학적, 분자유전학적인 특징과 후기 합병증에 대해 보고하는 바이다.

Keywords

References

  1. Chou JY, Matern D, Mansfield BC, Chen YT. Type I glycogen storage diseases: disorders of the glucose-6-phosphatase complex. Curr Mol Med 2002;2:121-43. https://doi.org/10.2174/1566524024605798
  2. Chou JY, Jun HS, Mansfield BC. Glycogen storage disease type I and G6Pase-$\beta$ deficiency: etiology and therapy. Nat Rev Endocrinol 2010;6:676-88. https://doi.org/10.1038/nrendo.2010.189
  3. Chou JY, Jun HS, Mansfield BC. Neutropenia in type Ib glycogen storage disease. Curr Opin Hematol 2010;17:36-42. https://doi.org/10.1097/MOH.0b013e328331df85
  4. Gerin I, Veiga-da-Cunha M, Achouri Y, Collet JF, Schaftingen EV. Sequence of a putative glucose-6-phosphate translocase, mutated in glycogen storage disease type 1b. FEBS Lett 1997;419:235-8. https://doi.org/10.1016/S0014-5793(97)01463-4
  5. Human Gene Mutation Database. [http://www.hgmd.cf.ac.uk].
  6. Visser G, Rake JP, Labrune P, Leonard JV, Moses S, Ullrich K, et al. Consensus guidelines for management of glycogen storagedisease type 1b - European Study on Glycogen Storage Disease Type 1. Eur J Pediatr 2002;168 Suppl 1:S120-S123.
  7. Lam CW, Chan KY, Tong SF, Chan BY, Chan YT, Chan YW. A novel missense mutation (P191L) in the glucose-6-phosphate translocase gene identified in a Chinese family with glycogen storage disease 1b. Hum Mutat 2000;16:94.
  8. Han SH, Ki CS, Lee JE, Hong YJ, Son BK, Lee KH, et al. A novel mutation (A148V) in the glucose 6-phosphate translocase (SLC37A4) gene in a Korean patient with glycogen storage disease type 1b. J Korean Med Sci 2005;20:499-501. https://doi.org/10.3346/jkms.2005.20.3.499
  9. Melis D, Parenti G, Della Casa R, Sibilio M, Berni Canani R, Terrin G, et al. Crohn's-like ileocolitis in patients affected by glycogenstorage disease Ib: two years' follow-up of patients with a wide spectrum of gastrointestinal signs. Acta Paediatr 2003;92:1415-21. https://doi.org/10.1080/08035250310007033
  10. Melis D, Fulceri R, Parenti G, Marcolongo P, Gatti R, Parini R, et al. Genotype/phenotype correlation in glycogen storage disease type 1b: a multicentre study and review of the literature. Eur J Pediatr 2005;164:501-8. https://doi.org/10.1007/s00431-005-1657-4
  11. Visser G, Rake JP, Kokke FT, Nikkels PG, Sauer PJ, Smit GP. Intestinal function in glycogen storage disease type 1. J Inherit Metab Dis 2002;25:261-7. https://doi.org/10.1023/A:1016572706488
  12. Wendel U, Schroten H, Burdach S, Wahn V. Glycogenstorage disease type1b: infectious complications and measuresfor prevention. Eur J Pediatr 1993;152 Suppl 1:S49-S51. https://doi.org/10.1007/BF02072088
  13. Donadieu J, Bader-Meunier B, Bertrand Y, Lachaux A, Labrune P, Gougerot MA, et al. Recombinant human G-CSF (Lenograstim) for infectious complications in glycogen storage disease type Ib. Report of 7 cases. Nouv Rev Fr Hematol 1994;35:529-34.
  14. Gitzelmann R, Bosshard NU. Defective neutrophil andmonocyte functions in glycogen storage disease type 1b: a literature review. Eur J Pediatr 1993;152 Suppl 1:S33-S38. https://doi.org/10.1007/BF02072085
  15. Froissart R, Piraud M, Boudjemline AM, Vianey-Saban C, Petit F, Hubert-Buron A, et al. Glucose-6-phosphatase deficiency. Orphanet Journal of Rare Diseases 2011;6:27 https://doi.org/10.1186/1750-1172-6-27
  16. Lee PJ, Patel JV, Fewtrel M, Leonard JV, Bishop NJ. Bone mineralisation in type 1 glycogen storage disease. Eur J Pediatr 1995;154:483-7. https://doi.org/10.1007/BF02029361
  17. Vivatrat N, Barshop BA, Jones KL. Severe hypertriglyceridemia and recurrent pancreatitis in a girl with type Ia glycogen storage disease and type III hyperlipoproteinemia. Am J Med Genet A 2009;149A:2557-9. https://doi.org/10.1002/ajmg.a.33046
  18. Boers SJ, Visser G, Smit PG, Fuchs SA. Liver transplantation in glycogen storage disease type I. Orphanet J Rare Dis 2014;9:47. https://doi.org/10.1186/1750-1172-9-47
  19. Lei KJ, Shelly LL, Lin B, Sidbury JB, Chen YT, Nordlie RC. Mutations in the glucose-6-phospha tase gene are associated with glycogen storage disease types 1a and 1aSP but not 1b and 1c. J Clin Investig 1995;95:234-40. https://doi.org/10.1172/JCI117645
  20. Galli L, Orrico A, Marcolongo P, Fulceri R, Burchell A, Melis D, et al. Mutations in the glucose-6 phosphate transporter (G6PT) gene in patients with glycogen storage diseases type 1b and 1c. FEBS Lett 1999,459:255-8. https://doi.org/10.1016/S0014-5793(99)01248-X
  21. Labrune P. Glycogen storage disease type I: indications for liver and/or kidney transplantation. Eur J Pediatr 2002;161 Suppl 1:S53-5. https://doi.org/10.1007/BF02679995
  22. Matern D1, Starzl TE, Arnaout W, Barnard J, Bynon JS, Dhawan A, et al. Liver transplantation for glycogen storage disease types I, III, and IV. Eur J Pediatr 1999;158 Suppl 2:S43-8. https://doi.org/10.1007/PL00014320
  23. Calderwood S, Kilpatrick L, Douglas SD, Freedman M, Smith-Whitley K, Rolland M, et al. Recombinant human granulocyte colony-stimulating factor therapy for patients with neutropenia and/or neutrophil dysfunction secondary to glycogen storage disease type 1b. Blood 2001;15:97:376-82. https://doi.org/10.1182/blood.V97.2.376
  24. George Kannourakis. Glycogen storage disease. Seminars in Hematology 2002;39:103-6. https://doi.org/10.1053/shem.2002.31920
  25. Kerr K. The prophylaxis of bacterial infections in neutropenic patients. J Antimicrob Chemother 1999;44:587-91. https://doi.org/10.1093/jac/44.5.587
  26. Melis D, Della Casa R, Parini R, Rigoldi M, Cacciapuoti C, Marcolongo P, et al. VitaminE supplementation improves neutropenia and reduces the frequency of infections in patients with glycogen storage disease type 1b. Eur J Pediatr 2009;168:1069-74. https://doi.org/10.1007/s00431-008-0889-5